← TrialMatch
HomeTrials

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemos

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after coronary angiography (CAG) or percutaneous coronary intervention (PCI). The main questions aims to answer: * What is the hemostatic effect of the patent hemosta

Condition(s)Percutaneous Coronary Intervention, Hemostasis
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after coronary angiography (CAG) or percutaneous coronary intervention (PCI). The main questions aims to answer: * What is the hemostatic effect of the patent hemostatic device with quantitative pressure after percutaneous coronary intervention? * What are the precise hemostatic pressure and hemostatic time of the radial artery after CAG/PCI? Participants will be randomly assigned to the intervention group (IG) and control group (CG). The IG will use patent hemostatic device with quantitative pressure (PHDQP-Band, China) while the CG will use the conventional radial artery hemostatic device (TR-Band, Japan) without pressure monitoring. Th
Who can participateInclusion Criteria: Patients undergoing coronary angiography or percutaneous coronary intervention via the radial artery; Positive Allen's test result; Willing to sign informed consent. Exclusion Criteria: Radial artery malformation; Chronic kidney disease with eGFR\<30ml/min.1.73m2; Cirrhosis of the liver; Coagulation disfunction; Patients treated with IIb / IIIa receptor antagonist.
Ages18 Years to 80 Years
SexAll
Lead sponsorPeking University First Hospital
LocationsBeijing, Beijing Municipality, China; Beijing, China
Start date2024-05-21
NCT IDNCT05790603
Official listinghttps://clinicaltrials.gov/study/NCT05790603

🔍 Search all trials →